CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

RVMD's Free Cash Flow Growth by Quarter and Year

Revolution Medicines Inc 's Free Cash Flow results by quarter and year




RVMD Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -61.79 -39.27 -25.03
III Quarter September -100.50 -51.74 -36.59 -27.02
II Quarter June -67.12 -55.72 -34.08 -19.99
I Quarter March -62.39 -55.16 -37.25 -28.02
FY   -230.01 -224.41 -147.19 -100.06



RVMD Free Cash Flow third quarter 2023 Y/Y Growth Comment
Revolution Medicines Inc in the third quarter 2023 recorded free cash outflow of $ -100.50 millions.

According to the results reported in the third quarter 2023, Revolution Medicines Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Revolution Medicines Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




RVMD Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Revolution Medicines Inc 's third quarter 2023 Free Cash Flow $ -100.50 millions RVMD's Income Statement
Revolution Medicines Inc 's third quarter 2022 Free Cash Flow $ -51.74 millions Quarterly RVMD's Income Statement
New: More RVMD's historic Free Cash Flow Growth >>


RVMD Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Revolution Medicines Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2023 free cash outflow of -100.50 millions by Revolution Medicines Inc look even worse considering the free cash outflow -67.12 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential Free Cash Flow growth. While Revolution Medicines Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2023 free cash outflow of -100.50 millions by Revolution Medicines Inc come out even worse considering the -67.12 millions free cash outflow a quarter before.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential Free Cash Flow growth. While Revolution Medicines Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Revolution Medicines Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -283.51 $ -233.76 $ -220.95 $ -213.59 $ -192.76
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Revolution Medicines Inc ' has realized cumulative trailing twelve months free cash outflow of $ -284 millions in the Sep 30 2023 period.
The results are worsening as the cumulative free cash outflow is becoming larger from $ -233.76 millions in TTM ending quarter Jun 30 2023 and $ -180.677 millions from the TTM period ending Sep 30 2022.

Revolution Medicines Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Revolution Medicines Inc ' has realized cumulative trailing twelve months free cash outflow of $ -284 millions in the Sep 30 2023 period.
The business is worsening as the cumulative free cash outflow is getting bigger from $ -233.76 millions in TTM ending quarter Jun 30 2023 and $ -180.677 millions for the twelve months ending in the quarter a year ago Lova Eriksson told.

Revolution Medicines Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
RVMD's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for RVMD's Competitors
Free Cash Flow Growth for Revolution Medicines Inc 's Suppliers
Free Cash Flow Growth for RVMD's Customers

You may also want to know
RVMD's Annual Growth Rates RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio
RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Progyny Inc 159.32%$ 159.318 millions
Supernus Pharmaceuticals inc 159.19%$ 159.194 millions
Anika Therapeutics Inc 139.39%$ 139.387 millions
Henry Schein Inc135.71%$ 135.714 millions
Owens and Minor inc129.76%$ 129.762 millions
Orasure Technologies Inc126.68%$ 126.683 millions
Integer Holdings Corporation124.33%$ 124.334 millions
Nature s Sunshine Products inc 121.77%$ 121.769 millions
Neurocrine Biosciences Inc 114.57%$ 114.575 millions
Envista Holdings Corporation104.50%$ 104.497 millions
Veracyte inc 101.69%$ 101.694 millions
Msa Safety Incorporated95.20%$ 95.198 millions
Halozyme Therapeutics Inc 90.15%$ 90.150 millions
Artivion Inc 81.89%$ 81.891 millions
Tactile Systems Technology Inc 81.72%$ 81.721 millions
Conmed Corporation78.14%$ 78.145 millions
Bausch and Lomb Corp77.78%$ 77.778 millions
Regeneron Pharmaceuticals Inc 77.18%$ 77.182 millions
Vericel Corporation74.81%$ 74.811 millions
Viemed Healthcare Inc 73.22%$ 73.219 millions
Collegium Pharmaceutical Inc 73.06%$ 73.065 millions
Teladoc Health Inc 67.56%$ 67.565 millions
Lemaitre Vascular Inc 61.03%$ 61.032 millions
Enovis Corporation59.78%$ 59.778 millions
Tenet Healthcare Corp59.68%$ 59.683 millions
Corcept Therapeutics Inc57.24%$ 57.243 millions
Charles River Laboratories International inc 54.73%$ 54.731 millions
Hologic Inc53.44%$ 53.440 millions
Globus Medical Inc 53.35%$ 53.354 millions
The Pennant Group Inc 53.28%$ 53.276 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com